Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

les laboratoires servier - trifluridine, tipiracil υδροχλωρική - Πρωτοπλαστικά νεοπλάσματα - Αντινεοπλασματικοί παράγοντες - colorectal cancerlonsurf is indicated in combination with bevacizumab for the treatment of adult patients with metastatic colorectal cancer (crc) who have received two prior anticancer treatment regimens including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and/or anti-egfr agents. lonsurf is indicated as monotherapy for the treatment of adult patients with metastatic colorectal cancer (crc) who have been previously treated with, or are not considered candidates for, available therapies including fluoropyrimidine-, oxaliplatin- and irinotecan-based chemotherapies, anti-vegf agents, and anti egfr agentsgastric cancerlonsurf is indicated as monotherapy for the treatment of adult patients with metastatic gastric cancer including adenocarcinoma of the gastroesophageal junction, who have been previously treated with at least two prior systemic treatment regimens for advanced disease.

Ευρωπαϊκή Ένωση - Ελληνικά - EMA (European Medicines Agency)

gilead sciences ireland uc - idelalisib - lymphoma, non-hodgkin; leukemia, lymphocytic, chronic, b-cell - antineoplastic agents, other antineoplastic agents - zydelig is indicated in combination with an anti‑cd20 monoclonal antibody (rituximab or ofatumumab) for the treatment of adult patients with chronic lymphocytic leukaemia (cll):who have received at least one prior therapy, oras first line treatment in the presence of 17p deletion or tp53 mutation in patients who are not eligible for any other therapies. zydelig is indicated as monotherapy for the treatment of adult patients with follicular lymphoma (fl) that is refractory to two prior lines of treatment.

Κύπρος - Ελληνικά - Φαρμακευτικών Υπηρεσιών του Υπουργείου Υγείας

medilink pharmaceuticals ltd (0000003162) 30 armenias, strovolos, 1640 , 26576 - triterpene glykosides calc - prolonged release capsule, hard - 50mg - triterpene glykosides calc (8000001789) 50mg - capillary stabilizing agents

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

demo abee - solvents and diluting agents,incl. rrigating solutions - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 14,9% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - solvents and diluting agents, incl. irrigating solutions

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vilco a.e. - other capillary stabilizing agents - ΔΙΣΚΙΟ - 20mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΦΥΤΙΚΗΣ ΠΡΟΕΛΕΥΣΗΣ - other capillary stabilizing agents

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

vilco a.e. - other capillary stabilizing agents - ΔΙΣΚΙΟ - 50mg/tab - ΦΑΡΜΑΚΕΥΤΙΚΑ ΠΡΟΪΟΝΤΑ ΦΥΤΙΚΗΣ ΠΡΟΕΛΕΥΣΗΣ - other capillary stabilizing agents

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

immunomedics europe, the netherlands - diagnostic agents - ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 0,31mg/vial - ΡΑΔΙΟΦΑΡΜΑΚΕΥΤΙΚΟ - diagnostic agents

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

medac gesellschaft fur klinische spezialpraparate mbh - detoxifying agents for antineoplastic treatment - ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΕΣΗ Η ΕΓΧΥΣΗ - 50mg/ml - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - detoxifying agents for cytostatic treatment

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

doctum ΦΑΡΜΑΚΕΥΤΙΚΗ Κ. ΓΙΟΚΑΡΗΣ & ΣΙΑ Α.Ε. - solvents and diluting agents,incl. rrigating solutions - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 5% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - solvents and diluting agents, incl. irrigating solutions

Ελλάδα - Ελληνικά - Εθνικός Οργανισμός Φαρμάκων

doctum ΦΑΡΜΑΚΕΥΤΙΚΗ Κ. ΓΙΟΚΑΡΗΣ & ΣΙΑ Α.Ε. - solvents and diluting agents,incl. rrigating solutions - ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ - 10% - ΦΑΡΜΑΚΕΥΤΙΚΟ ΠΡΟΪΟΝ - solvents and diluting agents, incl. irrigating solutions